Supernus Pharmaceuticals, Inc. (SUPN)

45.42 -1.74 (-3.69%) USD  |  NASDAQ  |  Dec 09, 16:00
45.42 0.00 (0.00%) After-Hours: 20:00
More

Supernus Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
CorMedix, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. --